Navigation Links
Synthetic eye prosthesis
Date:5/20/2010

This release is available in German.

For many patients who become blind after an accident or illness, a corneal transplantation could restore the ability to see. Each year, 40,000 people in Europe in Germany, about 7,000 await the opportunity to be able to see again, thanks to cornea donors. But donor corneas are not common. Dr. Joachim Storsberg of the Fraunhofer Institute for Applied Polymer Research IAP in Potsdam-Golm developed material and production process for a corneal prosthesis made of plastic. These can help patients who are unable to tolerate donor corneas due to the special circumstances of their disease, or whose donor corneas were likewise destroyed. In recognition of this accomplishment, Dr. Storsberg is being awarded the 2010 Joseph von Fraunhofer Prize.

The miniscale artificial cornea has to meet almost contradictory specifications: On the one hand, the material should grow firmly together with the cells of the surrounding tissue; on the other hand, no cells should settle in the optical region of the artificial cornea - i.e., the middle - since this would again severely impair the ability to see. And: The outer side of the implant must be able to moisten with tear fluids, otherwise the implant will cloud up on the anterior side. This would consequently require the patient to get a new prosthesis after a relatively brief period of time. And: The outer side of the implant must be able to moisten with tear fluid, so that the eyelid can slide across it without friction. Dr. Storsberg found the solution with a hydrophobic polymer material. This material has been in use for a long time in ophthalmology, such as for intraocular lenses. In order for it to satisfy the various characteristics required, complex development steps were necessary. The material was thoroughly modified on a polymer-chemical basis, and subsequently re-tested for public approval.

In order to achieve the desired characteristics, the edge of the implant was first coated with various, special polymers. Then, a special protein was added that contains the specific sequence of a growth factor. The surrounding natural cells detect this growth factor, are stimulated to propagate and populate the surface of the corneal margin. Thus, the cells of the surrounding tissue grow with the implant, and the artificial cornea attains stability. The eye prosthesis evolved jointly with physicians and manufacturers in the EU project, Artificial Cornea." The interdisciplinary research team needed three years to develop the artificial cornea. In a first step, they sent the chemical-biomimetic coated implant to Dr. Karin Kobuch of the Poliklinik fr Augenheilkunde at the Regensburg University Medical Center and to the medical center at the Technical University of Munich, on the right banks of the Isar river. The physician examined the artificial corneas in dissected pigs eyes and specialized cell cultures. Eventually, the team under Dr. Gernot Duncker and Dr. Saadettin Sel of the University Center for Ophthalmology in Halle (Saale) tested the more complex models in rabbits. There, the design was further refined: the optics were made smaller, and the implant haptic enlarged in order to maintain a more stable construction. Miro GmbH manufactured the implant, robin GmbH handled the distribution and sales and supported the specially adapted implantation centers in Europe. By 2009, a prosthesis was already successfully in use; further implantations are anticipated during the first six months of 2010.


'/>"/>

Contact: Dr. Joachim Storsberg
joachim.storsberg@iap.fraunhofer.de
49-331-568-1321
Fraunhofer-Gesellschaft
Source:Eurekalert  

Related medicine news :

1. Chemo Plus Synthetic Drug Shrunk Pancreatic Tumors
2. Chemotherapy plus synthetic compound provides potent anti-tumor effect in pancreatic cancers
3. Synthetic, dissolving plates ease repairs of nasal septum defects
4. Synthetic Platelets Put the Brakes on Blood Loss
5. Synthetic Red Blood Cells Developed
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Synthetic eye prosthesis
(Date:5/25/2016)... ... ... Cheryl Bowker of Bowker Insurance Group has been presented with one of ... McKenna ran one of Allstate’s most successful agencies for 48 years, but it was ... The award named for him is not given every year, but only when an ...
(Date:5/25/2016)... ... May 25, 2016 , ... Casa Velas, an adults-only ... of precious stones to complement its new wellness suites . The two 1,350 ... feature a plethora of special services and insuite amenities, from a custom soap selection ...
(Date:5/25/2016)... ... May 25, 2016 , ... Laser Skin & ... turn back the hands of time of female aging. The Juliet™ ... Women with symptoms such as leakage, laxity, itchiness and pain have reported real relief ...
(Date:5/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... as the Medical Director of its new DeSoto facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:5/24/2016)... ... May 24, 2016 , ... Sterling Global Products is ... unique and patented refillable hanging wipe dispenser. The campaign kick-off video is located via ... end June 25, 2016. The goal is to raise $1,000 per day for a ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... May 23, 2016 Transparency Market ... Exocrine Pancreatic Insufficiency Market - Global Industry Analysis, Size, ... According to the report, the exocrine pancreatic insufficiency market ... from 2015 to 2023 to reach US$2.85 Bn by ... condition characterized by the deficiency of the exocrine pancreatic ...
(Date:5/23/2016)... May 23, 2016 Clarifying Vision ... and Monitoring, and Vision Care What can ... are going to grow at the fastest rates? This ... 2026, assessing data, trends, opportunities and prospects. ... graphs. Discover the most lucrative areas in the industry ...
(Date:5/23/2016)... Non-invasive diagnostic test realizes the ... ,Technology to be presented at Yissum’s booth, at IATI-BIOMED ... Company of the Hebrew University of Jerusalem announced ... Aurum Ventures MKI, the technology investment arm of Morris ... approach for early detection of multiple diseases by analyzing ...
Breaking Medicine Technology: